As an HF biomarker, Galectin-3 may have a diagnostic and prognostic role (prognostic in both acute and chronic HF), since its expression is upregulated, especially in severe HF patients and in those with renal dysfunction. This evidence concerns the gene LGALS3 and Abnormal renal physiology.